rs875989805
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_001291867.2(NHS):c.694C>T(p.Gln232*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001291867.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Nance-Horan syndrome Pathogenic:1
- -
NHS-related disorder Pathogenic:1
The NHS c.694C>T variant is predicted to result in premature protein termination (p.Gln232*). This variant, previously reported as p.Q55X, has been documented in patients with Nance-Horan syndrome, including a female patient (Patient 5 in Fieremans et al 2016. PubMed ID: 27159028; Additional file 4 in Ling et al. 2019. PubMed ID: 30642278). This variant has not been reported in a large population database, indicating this variant is rare. Nonsense variants in NHS are expected to be pathogenic. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at